Semaglutide Significantly Improves Glycemia and Weight in Schizophrenia: JAMA
According to a new study published in JAMA Psychiatry, adjunctive semaglutide was shown to significantly improve glycemic control and weight outcomes in individuals with schizophrenia spectrum disorders receiving second-generation antipsychotics…